SG Americas Securities
IPSC icon

SG Americas Securities’s Century Therapeutics IPSC Stock Holding History

SG Americas Securities’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-25,314
Closed -$12K – 3257
2025
Q1 		$12K Buy
25,314
+5,931
+31% +$4.46K ﹤0.01% 3406
2024
Q4 		$20K Buy
19,383
+3,302
+21% +$4.5K ﹤0.01% 3013
2024
Q3 		$27K Buy
+16,081
New +$31.5K ﹤0.01% 3331
2024
Q1 		– Sell
-12,818
Closed -$43K – 3193
2023
Q4 		$43K Buy
12,818
+2,478
+24% +$4.51K ﹤0.01% 2940
2023
Q3 		$21K Buy
+10,340
New +$27.5K ﹤0.01% 3043
2023
Q1 		– Sell
-10,368
Closed -$53K – 3405
2022
Q4 		$53K Buy
+10,368
New +$97.9K ﹤0.01% 2834
2021
Q4 		– Sell
-5,314
Closed -$134K – 3590
2021
Q3 		$134K Buy
+5,314
New +$144K ﹤0.01% 3506

Other funds holding IPSC

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SG Americas Securities's IPSC Position: Q2 2025 in Review

SG Americas Securities sold out of Century Therapeutics (IPSC) in Q2 2025, closing a stake of 25,314 shares — an estimated $12K sold.

SG Americas Securities first reported a position in IPSC in Q3 2021 and held it in 7 quarters. The position peaked at $134K in Q3 2021. 65 funds tracked by Wall St. Rank hold IPSC as of Q2 2025.

  • SG Americas Securities reported no remaining Century Therapeutics position as of Q2 2025 after selling out during the quarter.
  • SG Americas Securities sold 25,314 Century Therapeutics shares in Q2 2025, an estimated $12K.
  • SG Americas Securities first reported a position in Century Therapeutics in Q3 2021 and held it in 7 quarters.
  • SG Americas Securities's Century Therapeutics position peaked at $134K in Q3 2021.
  • 65 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2025.

Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.